Labshake search

1 - 13 of 13 citations for Breast Cancer Type 1 Susceptibility Protein BRCA1 Antibody since 2019

• Batf-mediated Epigenetic Control of Effector CD8+ T Cell Differentiation

  Hsiao-Wei Tsao, et al., bioRxiv - Immunology 2021

  Quote: ... The following primary antibodies were used to detect designated proteins: Batf (Brookwood Biomedical, PAB4003), Irf4 (Santa Cruz ...
• A live attenuated vaccine confers superior mucosal and systemic immunity to SARS-CoV-2 variants

  Geraldine Nouailles, et al., bioRxiv - Immunology 2022

  Quote: ... and rabbit anti hamster IgA antibody (Brookwood Biomedical, Jemison, AL, dilution: 1:250) were incubated at 4°C overnight followed by washing and incubation with a secondary biotinylated goat anti-mouse IgG antibody (dilution ...
• Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection

  Gabriela Baldeon Vaca, et al., bioRxiv - Immunology 2023

  Quote: ... or HRP-conjugated rabbit anti-hamster IgA antibodies (1:5,000; Brookwood Biomedical; sab3003) for 1 hour at 37°C ...
• Immunogenicity and efficacy of a subcutaneously administered, adjuvanted vaccine containing modified S1 spike protein of SARS-CoV-2 variant C.1.2

  Michael Bowe, et al., bioRxiv - Immunology 2023

  Quote: ... and secondary IgA and IgM antibodies (Brookwood Biomedical).
• Batf-mediated Epigenetic Control of Effector CD8+ T Cell Differentiation

  Hsiao-Wei Tsao, et al., bioRxiv - Immunology 2021

  Quote: ... Antibodies used in HiChIP experiments: Batf (Brookwood Biomedical, PAB4003) and Ctcf (Millipore ...
• Batf-mediated Epigenetic Control of Effector CD8+ T Cell Differentiation

  Hsiao-Wei Tsao, et al., bioRxiv - Immunology 2021

  Quote: ... Antibodies used in ChIP-seq: Batf (Brookwood Biomedical, PAB4003), Jund (Santa Cruz ...
• Immunogenicity and efficacy of a subcutaneously administered, adjuvanted vaccine containing modified S1 spike protein of SARS-CoV-2 variant C.1.2

  Michael Bowe, et al., bioRxiv - Immunology 2023

  Quote: ... Secondary IgM or IgA antibody conjugated to alkaline phosphatase (Brookwood Biomedical) was added in Blocker at a dilution of 1:100 to each well and incubated for 1 hour at RT on a plate rocker ...
• A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants

  Linglei Jiang, et al., bioRxiv - Immunology 2022

  Quote: ... IgA (1:250, Brookwood Biomedical, AL, USA) or IgM (1:250 ...
• Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model

  Santosh Dhakal, et al., bioRxiv - Microbiology 2021

  Quote: ... IgA (1:250, Brookwood Biomedical, AL, USA) or IgM (1:250 ...
• A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants

  Linglei Jiang, et al., bioRxiv - Immunology 2022

  Quote: ... or IgM (1:250, Brookwood Biomedical, AL, USA) antibodies were added ...
• Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model

  Santosh Dhakal, et al., bioRxiv - Microbiology 2021

  Quote: ... or IgM (1:250, Brookwood Biomedical, AL, USA) antibodies were added ...
• A live attenuated vaccine confers superior mucosal and systemic immunity to SARS-CoV-2 variants

  Geraldine Nouailles, et al., bioRxiv - Immunology 2022

  Quote: ... The plates were covered and incubated for 2 h at room temperature before the washing step was repeated and 50 μL of secondary antibody (Brookwood biomedical, Rabbit Anti-Hamster IgA ...
• An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission

  Weizhong Li, et al., bioRxiv - Immunology 2022

  Quote: ... HRP-conjugated anti-hamster IgA (1:250, Brookwood Biomedical, Cat# sab3003a) was used ...